InMode Ltd INMD

What the company does

InMode Ltd is a small-cap company in the Healthcare sector (Medical Devices), with a market value of $818M, based in the USA.

It employs about 660 people and has been listed since Aug 08, 2019.

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. It offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.

Cheap or expensive? relatively cheap

Its price-to-earnings (P/E) is 11.7 versus 32.8 for the median of the Healthcare sector in our universe (25 companies) — relatively cheap.

Revenue is growing 0% versus the same quarter last year.

On analysts' next-year forecasts the multiple drops to 10.0 — they expect higher earnings.

The average analyst price target is 16.17, 14% above the current price (their view, not ours).

The stock sits at 38% of its one-year range (0% = the low, 100% = the high).

The risks

• • The stock is more volatile than average (beta 2.0) — big daily moves both ways.

Strengths

• ✅ Profitable — 18 of every 100 dollars of revenue stays as profit.
• ✅ Generates free cash flow — profit becomes cash in the bank.
• ✅ Buys back its shares (7% fewer shares in a year).
• ✅ More cash than debt.

What changed this week

Over the past week the stock rose 0.8% (for comparison: S&P 500 +1.2%, sector ETF XLV +2.8%).

No notable news about the company was found in the past week.

What changed since last week

This is the first summary for this stock; from next week this section shows what changed.